The Motley Fool

Key Data Points

Primary metrics and data points about Acorda Therapeutics, Inc..
Current Price: $33.78
Prev Close: $34.61
Open: $34.66
Bid: $0.00
Ask: $39.00
Day's Range: $33.38 - $34.97
52wk Range: $28.26 - $45.45
Volume: 494,530
Avg Vol 512,704
Market Cap: $1B
P/E (ttm): 101.79
EPS (ttm): $0.34
Div & Yield: $0.00 (0.0%)

Business Summary

Industry, sector and description for Acorda Therapeutics, Inc..

A commercial-stage biopharmaceutical company dedicated to the identification, development & commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the CNS.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

ACOR vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Acorda Therapeutics, Inc..
CAPS Rating 4 out of 5
 
217 Outperform
89 Underperform
CAPS All Stars
 
59 Outperform
20 Underperform

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Ron Cohen, CEO

64% Approve

Based on 11 Ratings

Powered by

More Details about Acorda Therapeutics, Inc.

Primary metrics and data points about Acorda Therapeutics, Inc..